The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Souza, W. N.
Right arrow Articles by Lefrançois, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Souza, W. N.
Right arrow Articles by Lefrançois, L.
The Journal of Immunology, 2003, 171: 5727-5735.
Copyright © 2003 by The American Association of Immunologists

IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion 1

Warren N. D’Souza and Leo Lefrançois2

Department of Medicine, Division of Immunology, University of Connecticut Health Center, Farmington, CT 06030

Based primarily on in vitro data, IL-2 is believed to be the key cytokine for initiation of the cell cycle of activated T cells. However, the role of IL-2 remains unresolved for T cell responses in vivo. We examined whether the absence of IL-2-mediated signaling in CD8 T cells affected initiation of proliferation. Our results conclusively demonstrated that initial division of Ag-specific CD8 T cells following priming was IL-2 independent, regardless of the context in which Ag was presented. In contrast, the latter stage of the proliferative phase was IL-2-dependent, particularly in nonlymphoid tissues. Thus, activated CD8 T cells initially undergo IL-2-independent proliferation, but reach a critical juncture where the requirement for IL-2 as a growth factor gains prominence.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Maroof, L. Beattie, A. Kirby, M. Coles, and P. M. Kaye
Dendritic Cells Matured by Inflammation Induce CD86-Dependent Priming of Naive CD8+ T Cells in the Absence of Their Cognate Peptide Antigen
J. Immunol., December 1, 2009; 183(11): 7095 - 7103.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. McCarron and D. J. Reen
Activated Human Neonatal CD8+ T Cells Are Subject to Immunomodulation by Direct TLR2 or TLR5 Stimulation
J. Immunol., January 1, 2009; 182(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. N. D'Souza, C.-F. Chang, A. M. Fischer, M. Li, and S. M. Hedrick
The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival
J. Immunol., December 1, 2008; 181(11): 7617 - 7629.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kamimura and M. J. Bevan
Endoplasmic Reticulum Stress Regulator XBP-1 Contributes to Effector CD8+ T Cell Differentiation during Acute Infection
J. Immunol., October 15, 2008; 181(8): 5433 - 5441.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. K. L. MacLeod, A. McKee, F. Crawford, J. White, J. Kappler, and P. Marrack
CD4 memory T cells divide poorly in response to antigen because of their cytokine profile
PNAS, September 23, 2008; 105(38): 14521 - 14526.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xiao, V. Peperzak, A. M. Keller, and J. Borst
CD27 Instructs CD4+ T Cells to Provide Help for the Memory CD8+ T Cell Response after Protein Immunization
J. Immunol., July 15, 2008; 181(2): 1071 - 1082.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Robertson, R. J. Messer, A. B. Carmody, R. S. Mittler, C. Burlak, and K. J. Hasenkrug
CD137 Costimulation of CD8+ T Cells Confers Resistance to Suppression by Virus-Induced Regulatory T Cells
J. Immunol., April 15, 2008; 180(8): 5267 - 5274.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Yang, E. M. Wall, K. Milne, P. Theiss, P. Watson, and B. H. Nelson
CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15 Dependent Mechanism
Clin. Cancer Res., December 1, 2007; 13(23): 7172 - 7180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Hwang, J. R. Lukens, and T. N. J. Bullock
Cognate Memory CD4+ T Cells Generated with Dendritic Cell Priming Influence the Expansion, Trafficking, and Differentiation of Secondary CD8+ T Cells and Enhance Tumor Control
J. Immunol., November 1, 2007; 179(9): 5829 - 5838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Filby, B. Seddon, J. Kleczkowska, R. Salmond, P. Tomlinson, M. Smida, J. A. Lindquist, B. Schraven, and R. Zamoyska
Fyn Regulates the Duration of TCR Engagement Needed for Commitment to Effector Function
J. Immunol., October 1, 2007; 179(7): 4635 - 4644.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Blair and L. Lefrancois
Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells
PNAS, September 18, 2007; 104(38): 15045 - 15050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Hommel and P. D. Hodgkin
TCR Affinity Promotes CD8+ T Cell Expansion by Regulating Survival
J. Immunol., August 15, 2007; 179(4): 2250 - 2260.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Kamimura and M. J. Bevan
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo
J. Exp. Med., August 6, 2007; 204(8): 1803 - 1812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Casey and M. F. Mescher
IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype
J. Immunol., June 15, 2007; 178(12): 7640 - 7648.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Carr, M. J. Carrasco, J. E. D. Thaventhiran, P. J. Bambrough, M. Kraman, A. D. Edwards, A. Al-Shamkhani, and D. T. Fearon
CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation
PNAS, December 19, 2006; 103(51): 19454 - 19459.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. S. Sheridan, K. M. Khanna, G. M. Frank, and R. L. Hendricks
Latent Virus Influences the Generation and Maintenance of CD8+ T Cell Memory
J. Immunol., December 15, 2006; 177(12): 8356 - 8364.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yu and T. R. Malek
Selective Availability of IL-2 Is a Major Determinant Controlling the Production of CD4+CD25+Foxp3+ T Regulatory Cells
J. Immunol., October 15, 2006; 177(8): 5115 - 5121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Pejawar-Gaddy and M. A. Alexander-Miller
Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes
J. Immunol., October 1, 2006; 177(7): 4495 - 4502.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Prlic, G. Hernandez-Hoyos, and M. J. Bevan
Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response
J. Exp. Med., September 4, 2006; 203(9): 2135 - 2143.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. N. D'Souza and S. M. Hedrick
Cutting Edge: Latecomer CD8 T Cells Are Imprinted with a Unique Differentiation Program
J. Immunol., July 15, 2006; 177(2): 777 - 781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. H. Cornish, L. V. Sinclair, and D. A. Cantrell
Differential regulation of T-cell growth by IL-2 and IL-15
Blood, July 15, 2006; 108(2): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Antony, C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, et al.
Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo
J. Immunol., May 1, 2006; 176(9): 5255 - 5266.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Le Bon, V. Durand, E. Kamphuis, C. Thompson, S. Bulfone-Paus, C. Rossmann, U. Kalinke, and D. F. Tough
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming.
J. Immunol., April 15, 2006; 176(8): 4682 - 4689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Verdeil, D. Puthier, C. Nguyen, A.-M. Schmitt-Verhulst, and N. Auphan-Anezin
STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors.
J. Immunol., April 15, 2006; 176(8): 4834 - 4842.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Jin, D. Gong, D. Adeegbe, A. L. Bayer, C. Rolle, A. Yu, and T. R. Malek
Quantitative assessment concerning the contribution of IL-2R{beta} for superantigen-mediated T cell responses in vivo
Int. Immunol., April 1, 2006; 18(4): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Krieg, P. Han, R. Stone, O. D. Goularte, and J. Kaye
Functional Analysis of B and T Lymphocyte Attenuator Engagement on CD4+ and CD8+ T Cells
J. Immunol., November 15, 2005; 175(10): 6420 - 6427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Barouch-Bentov, E. E. Lemmens, J. Hu, E. M. Janssen, N. M. Droin, J. Song, S. P. Schoenberger, and A. Altman
Protein Kinase C-{theta} Is an Early Survival Factor Required for Differentiation of Effector CD8+ T Cells
J. Immunol., October 15, 2005; 175(8): 5126 - 5134.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. A. Kolumam, S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
J. Exp. Med., September 6, 2005; 202(5): 637 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. G. Brooks, L. Teyton, M. B. A. Oldstone, and D. B. McGavern
Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection
J. Virol., August 15, 2005; 79(16): 10514 - 10527.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Carlow, M. J. Williams, and H. J. Ziltener
Inducing P-Selectin Ligand Formation in CD8 T Cells: IL-2 and IL-12 Are Active In Vitro but Not Required In Vivo
J. Immunol., April 1, 2005; 174(7): 3959 - 3966.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sundstrom, S. Ota, L. Y. Dimberg, M. G. Masucci, and A. Bergqvist
Hepatitis C Virus Core Protein Induces an Anergic State Characterized by Decreased Interleukin-2 Production and Perturbation of Mitogen-Activated Protein Kinase Responses
J. Virol., February 15, 2005; 79(4): 2230 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams and M. J. Bevan
Shortening the Infectious Period Does Not Alter Expansion of CD8 T Cells but Diminishes Their Capacity to Differentiate into Memory Cells
J. Immunol., December 1, 2004; 173(11): 6694 - 6702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kamimura, N. Ueda, Y. Sawa, S. Hachida, T. Atsumi, T. Nakagawa, S.-i. Sawa, G.-H. Jin, H. Suzuki, K. Ishihara, et al.
Evidence of a Novel IL-2/15R{beta}-Targeted Cytokine Involved in Homeostatic Proliferation of Memory CD8+ T Cells
J. Immunol., November 15, 2004; 173(10): 6041 - 6049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Teague, R. M. Tempero, S. Thomas, K. Murali-Krishna, and B. H. Nelson
Proliferation and Differentiation of CD8+ T Cells in the Absence of IL-2/15 Receptor {beta}-Chain Expression or STAT5 Activation
J. Immunol., September 1, 2004; 173(5): 3131 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Mihalyo, A. D. H. Doody, J. P. McAleer, E. C. Nowak, M. Long, Y. Yang, and A. J. Adler
In Vivo Cyclophosphamide and IL-2 Treatment Impedes Self-Antigen-Induced Effector CD4 Cell Tolerization: Implications for Adoptive Immunotherapy
J. Immunol., May 1, 2004; 172(9): 5338 - 5345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.